In a world first, scientists have found a new way to direct stem cells to heart tissue. The findings, led by researchers at the University of Bristol and published in Chemical Science, could radically improve the treatment for cardiovascular disease, which causes more than a quarter of all deaths in the UK.
To date, trials using stem cells, which are taken and grown from the patient or donor and injected into the patient’s heart to regenerate damaged tissue, have produced promising results.
However, while these next generation cell therapies are on the horizon, significant challenges associated with the distribution of the stem cells have remained. High blood flow in the heart combined with various ’tissue sinks’, that circulating cells come into contact with, means the majority of the stem cells end up in the lungs and spleen.
Now, researchers from Bristol’s School of Cellular and Molecular Medicine have found a way to overcome this by modifying stem cells with a special protein so they ‘home’ to heart tissue.
Dr Adam Perriman, the study’s lead author, Associate Professor in Biomaterials, UKRI Future Leaders Fellow and founder of the cell therapy technology company CytoSeek, explained: “With regenerative cell therapies, where you are trying to treat someone after a heart attack, the cells rarely go to where you want them to go. Our aim is to use this technology to re-engineer the membrane of cells, so that when they’re injected, they’ll home to specific tissues of our choice.
“We know that some bacterial cells contain properties that enable them to detect and ‘home’ to diseased tissue. For example, the oral bacterial found in our mouths can occasionally cause strep throat. If it enters the blood stream it can ‘home’ to damaged tissue in the heart causing infective endocarditis. Our aim was to replicate the homing ability of bacteria cells and apply it to stem cells.”
The team developed the technology by looking at how bacterial cells use a protein called an adhesin to ‘home’ to heart tissue. Using this theory, the researchers were able to produce an artificial cell membrane binding version of the adhesin that could be ‘painted’ on the outside of the stem cells. In an animal model, the team were able to demonstrate that this new cell modification technique worked by directing stem cells to the heart in a mouse.
Dr Perriman added: “Our findings demonstrate that the cardiac homing properties of infectious bacteria can be transferred to human stem cells. Significantly, we show in a mouse model that the designer adhesin protein spontaneously inserts into the plasma membrane of the stem cells with no cytotoxity, and then directs the modified cells to the heart after transplant. To our knowledge, this is the first time that the targeting properties of infectious bacteria have been transferred to mammalian cells.
“This new technique carries enormous potential for the seven million people currently living with heart disease in the UK.”
Learn more: Scientists hijack bacteria’s homing ability
The Latest on: Cardiovascular disease
[google_news title=”” keyword=”cardiovascular disease” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Cardiovascular disease
- Too Much Calcium at Dinner Raises Cardiovascular Disease Riskon May 11, 2024 at 5:59 am
A study has found that excessive calcium intake during dinner could increase cardiovascular disease risk. The research, published in BMC Public Health, suggests that consuming a significant amount of ...
- Heart Disease Newson May 10, 2024 at 5:00 pm
Solving the Riddle of the Sphingolipids in Coronary Artery Disease Apr. 24, 2024 — Investigators have uncovered a way to unleash in blood vessels the protective effects of a type of fat-related ...
- How Are Menopause Age, Cardiovascular Disease Risk, and Cognition Related?on May 10, 2024 at 7:16 am
Menopausal hormonal changes and vascular risk factors have been implicated in risk for Alzheimer disease. Researchers studied the link between age at menopause, vascular risk, and prospective ...
- Exercise Reduces Stress and Risk of Heart Diseaseon May 9, 2024 at 9:00 am
Exercise is essential for heart health, especially for those with depression and other mental health disorders. | Cardiology ...
- What We’re Reading: US Adults at Risk of Heart Disease; Youth Mental Health, Addiction Support; FDA Postpones Meeting on Next COVID Vaccine Strainon May 9, 2024 at 8:04 am
Research shows a high prevalence of cardiovascular-kidney-metabolic (CKM) syndrome among adults; tackling mental health and substance abuse nationwide; a delayed meeting allows for surveillance data ...
- Panel reviews heart disease risks, preventionon May 8, 2024 at 2:59 pm
The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.
- About 90% of US adults are on the way to heart disease, study suggestson May 8, 2024 at 2:00 pm
Nine of 10 American adults are in the early, middle or late stages of a syndrome that leads to heart disease, a new report finds, and almost 10% have the disease already.
- Nine in 10 U.S. adults have syndrome that leads to heart diseaseon May 8, 2024 at 10:56 am
Nine of 10 American adults are in the early, middle or late stages of a syndrome that leads to heart disease, a new report finds, and almost 10% have the disease already.
- Entresto puts Novartis at top of docs' ranking of heart disease drug makers, with Pfizer close behindon May 7, 2024 at 1:30 pm
In an ongoing battle for dominance in the eyes of healthcare professionals for their work developing heart disease-focused drugs, Novartis has now snatched the top spot from Pfizer, according to a ...
- Evidence Builds to Support Colchicine in Treating Atherosclerotic Cardiovascular Diseaseon May 6, 2024 at 8:32 am
Colchicine, a legacy drug that received a new indication in 2023 for cardiovascular disease, can treat arterial inflammation after a heart attack, a principal investigator of clinical trials said.
via Bing News